Výsledky vyhledávání - Angela D’Angelo
- Zobrazuji výsledky 1 - 20 z 22
- Přejít na další stránku
-
1
-
2
-
3
Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlle... Autor Giuseppe, Derosa, Angela, D’Angelo, Davide, Romano, Pamela, Maffioli
Vydáno 2017Text -
4
-
5
-
6
-
7
-
8
-
9
-
10
Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers Autor Valeria Brazzelli, Pamela Maffioli, Vittorio Bolcato, Christian Ciolfi, Angela D’Angelo, Carmine Tinelli, Giuseppe Derosa
Vydáno 2021Artigo -
11
-
12
Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells Autor Valentina Masola, Giovanni Gambaro, Elena Tibaldi, Anna Maria Brunati, Alessandra Gastaldello, Angela D’Angelo, Maurizio Onisto, Antonio Lupo
Vydáno 2011Artigo -
13
Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis Autor Sandro Giannini, M. Nobile, Leonardo Sartori, Luca Dalle Carbonare, Matteo Ciuffreda, Paolo Corrò, Angela D'Angelo, Lorenzo A. Calò, Gaetano Crepaldi
Vydáno 1999Artigo -
14
Galectin-3 Plasma Levels and Coronary Artery Disease: A New Possible Biomarker of Acute Coronary Syndrome Autor Colomba Falcone, Simona Lucibello, Iolanda Mazzucchelli, Sara Bozzinì, Angela D’Angelo, Sandra Schirinzi, Rossana Totaro, Rossana Falcone, M. Bondesan, Gabriele Pelissero
Vydáno 2011Artigo -
15
Effects of dietary protein and phosphorus restriction on the progression of early renal failure Autor Giuseppe Maschio, Lamberto Oldrizzi, Nicola Tessitore, Angela D’Angelo, E. Valvo, Antonio Lupo, C. Loschiavo, Antonia Fabris, Linda Gammaro, Carlo Rugiu, Giovanni Panzetta
Vydáno 1982Artigo -
16
Alendronate Prevents Further Bone Loss in Renal Transplant Recipients Autor Sandro Giannini, Angela D’Angelo, Gianni Carraro, M. Nobile, Paolo Rigotti, Luciana Bonfante, Francesco Marchini, Martina Zaninotto, Luca Dalle Carbonare, Leonardo Sartori, G Crepaldi
Vydáno 2001Artigo -
17
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone Autor Giuseppe Derosa, Elena Fogari, Angela D’Angelo, Arrigo F.G. Cicero, Sibilla Salvadeo, P. D. Ragonesi, Ilaria Ferrari, Alessia Gravina, Raffaella Fassi, Roberto Fogari
Vydáno 2007Artigo -
18
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial Autor Giuseppe Derosa, Luigina Guasti, Angela D’Angelo, Chiara Martinotti, Maria Chiara Valentino, Sergio Di Matteo, Giacomo Matteo Bruno, Andrea Maria Maresca, Giovanni Gaudio, Pamela Maffioli
Vydáno 2022Artigo -
19
Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-.ALPHA. Autor Giuseppe Derosa, Arrigo F.G. Cicero, Angela D’Angelo, Pietro D. Ragonesi, Leonardina Ciccarelli, Mario N. Piccinni, F. Pricolo, Sibilla Salvadeo, Ilaria Ferrari, Alessia Gravina, Roberto Fogari
Vydáno 2006Artigo -
20
Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome Autor Giuseppe Derosa, Angela D’Angelo, P. D. Ragonesi, Leonardina Ciccarelli, Mario N. Piccinni, F. Pricolo, Sibilla Salvadeo, Lorenza Montagna, Alessia Gravina, Ilaria Ferrari, S. Paniga, Arrigo F.G. Cicero
Vydáno 2006Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Endocrinology
Diabetes mellitus
Type 2 diabetes
Biochemistry
Body mass index
Chemistry
Gastroenterology
Pathology
Biology
Insulin resistance
Alternative medicine
Antioxidant
Blood pressure
Calcium
Creatinine
Disease
Insulin
Placebo
Resistin
Rosiglitazone
Adipokine
Adiponectin
Cardiology
Coronary artery disease
Gene
Irbesartan
Lipid profile
Metabolic syndrome